Corporate Members
STA 2023 Corporate Membership
CLICK HERE to download the 2023 Corporate Membership Prospectus
CLICK HERE to register as a 2023 Corporate Member
Corporate Members have been, and always will be, central to STA’s mission. The interaction between users and developers of technology is unique to STA, enhancing patient care and our collective ability to innovate. By becoming a Corporate Member, you will also receive many benefits, including the opportunity to interact at the 2023 STA Annual Meeting, and have invaluable opportunities to interact with the STA leaders and membership. Sustaining Corporate Members and creating value in this unique relationship
Sustaining Corporate Member
Sustaining Platinum Plus, Platinum and Gold Corporate Members make a 3-year commitment to membership and receive exclusive benefits in addition to those received by Annual Corporate Members.
Annual Corporate Member
Depending on your level of Annual Corporate Membership, you can correspond with the membership via the STA listserv, Slack Channel and online member directory, advertise on the STA website, onsite Annual Meeting syllabus and Interface Newsletter, exhibit and attend the Annual Meeting, hold a private focus group at the Annual Meeting and much more!
If you should have any questions regarding your Corporate Membership registration or benefits, please contact the STA office by email at marie@stahq.org or by phone at 414-389-8600. We look forward to hearing from you!
2023 Sustaining Corporate Members
Platinum Plus Members
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
Platinum Members
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. We optimize OR workplaces for efficient anesthesia delivery using innovative equipment with intuitive user interfaces. Our proven anesthesia machines are uniquely designed to protectively ventilate patients and help reduce the risk for postoperative pulmonary complications. Our perioperative care portfolio supports your surgical teams because it’s technically sophisticated without being complicated. With advanced workplace designs, anesthesia machines, accessories, monitoring, service, and clinical information management solutions, we promote safety and efficiency in your OR.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services and data analytics that make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $18 billion business with 51,000 employees working to create a world where healthcare has no limits.
2023 Annual Corporate Members
Platinum Plus Members
Medtronic Patient Monitoring & Respiratory Interventions offers medical devices & services, VBHC programs and education to healthcare professionals working in the Emergency Department, OR, ICU, Medical-Surgical as well as post- acute settings.
Together, we strive for zero adverse events, contributing to patient safety and reducing healthcare costs.
Platinum Members
Spanning patient monitoring, anesthesia, and ultrasound, Mindray empowers healthcare professionals through innovative, high-value solutions that help create the next generation of lifesaving tools. But Mindray is more than just products and services. We believe in solutions that address your biggest perioperative challenges, such as patient safety, improved patient outcomes, and streamlined workflow in the Operating Room. We recognize the human side of healthcare and your role in providing best-in-class patient care, which is why we create products suited to your clinical needs in this environment.
Our portfolio of perioperative products optimizes your OR workflow through intuitively designed systems and enhances patient care with reliable and safe functionality. Our team of perioperative specialists ensure that your clinical teams are educated, trained, and up-to-date on these solutions. Trust Mindray for your complete perioperative solution. Together, we are creating a higher standard for healthcare.
Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world.
Silver Members
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.
The company partners with organizations around the world to address some of the most challenging global health issues.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.
Entrepreneur Gold Member
Micropore's patented membrane-based technology was invented by Professor Richard Holdich, former Head of the Chemical Engineering Department at the internationally respected Loughborough University in the UK. Micropore Technologies was set up in 2003 to commercialise this unique new technology and now operates globally with a head quarters in the north east of England and offices in the USA, India, South Korea and Japan.
Meet the new ISMP Guidelines with Safe Label System (SLS), a medication verification safety system used in perioperative and procedural settings to improve anesthesia workflow and patient safety. During preparation, when a drug is scanned on SLS, it electronically reads the manufacturer’s vial/ampoule barcode and visually and audibly identifies the drug name and concentration, acting as a second set of eyes to ensure safety, then prints a full-color TJC-compliant syringe label. Every label includes a barcode, enabling integration with AIMS/EHR (Epic/Cerner), providing additional safety and ‘hands-free’ documentation at administration. Additionally, the syringe label barcode enables smart infusion pump interoperability that allows the pump to be programmed with a scan of the label and just four clicks. Changes made to the pump are automatically documented into Epic without any additional interaction, increasing documentation accuracy, clinician efficiency, and patient safety. Once the syringe is wasted and returned, it can be scanned into WasteLog™ from Codonics, a drug assay device which instantly identifies the expected narcotic, concentration and preparer, plus analyzes and reports what’s actually in the syringe in <4 seconds, helping to detect and deter drug diversion. Together, we can eliminate medication errors. Visit us for a demonstration.
The Extrico platform simplifies and standardizes the extraction and utilization of data from the electronic health record in three stages, extracting of raw data from the EHR, cleaning and standardizing the raw data to allow for scalability, and transformation of the standardized data into actionable insights. Foundational to the Platform is Extrico’s phenotype* technology - called InfoTypes, that combine multiple data points to create a single piece of usable information, such as identifying patients with a given chronic illness by looking at past lab results, medications taken, and billing codes simultaneously.
Perioperative reporting in analytics is a complex domain requiring expertise in OR operations, procedural nomenclature and understanding of the unique medical issues that affect operative patients. Perioperative care does not start or stop at the operating room door, and neither does the KnowledgeBase. Extrico’s platform contains all the data in the EHR, allowing integration of preoperative baselines and tracking of postoperative outcomes even well past discharge.
The KnowledgeBase was built by practicing anesthesiologists with deep knowledge of OR operations and analytics. The Platform has been successfully used by anesthesia departments and OR management at top 10 academic medical centers to gain rapid access to actionable insights for retrospective research, improved increase operational efficiency, optimize staffing decisions, quality improvement projects, and increase perioperative billing.
Entrepreneur Silver Members
AlertWatch develops integrated decision support software to help anesthesiologists improve quality, safety, and efficiency across the entire continuum of care. The software integrates device and medical record information to produce real-time alerts focused on improving outcomes and reducing length of stay.
AlertWatch:OR - This application consolidates hundreds of real-time and historical data elements onto intuitive multi- patient and single-patient dashboards. With AlertWatch:OR, clinicians can track real-time patient status and case progress at a glance, including sophisticated alerts and clinical decision support built for the perioperative workflow. The solution is now being used, under IRB, to monitor hundreds of rooms from a Tele-OR facility. Reach out to learn more about this innovative use case.
AlertWatch:OB - This application tracks each mother throughout the entire labor, delivery and post-delivery process, automatically assessing hemorrhage risk and related clinical issues and alerting for emerging clinical issues. By providing a complete clinical picture for each patient, AlertWatch:OB will become a key piece of your maternal safety efforts. Research has shown that our proprietary alerting algorithms are more effective at identifying hemorrhages than the existing national guidelines.
AlertWatch:AC - This application, pending FDA clearance, helps clinicians oversee all types of acute care patients in the ICU and lower acuity settings in the hospital. The solution has powerful clinical decision support built for ECMO and ventilated patients, and also helps clinicians improve their response to sepsis. AlertWatch:AC will be the foundation to your future telehealth initiatives.
AlertWatch:PACU - This application, pending FDA clearance, helps anesthesiologists remotely monitor and discharge PACU patients. The solution passes on useful analysis from intraoperative data and helps the entire care team provide more consistent care. This solution is now being used, under IRB, to remotely sign out PACU patients. Reach out to learn more about this innovative use case.
AlertWatch:RPM: We have partnered with BioIntelliSense, makers of innovative wearable sensors, to enable continuous remote monitoring of patients in low acuity units, and after they leave the hospital. The combined solution will enable anesthesia to expand their services beyond the standard perioperative environments.
Makers of the TwitchView train of four (TOF) monitor, the only quantitative neuromuscular monitor clinically validated against gold standard mechanomyography (MMG). TwitchView utilizes expert-recommended electromyography (EMG) to reliably guide management and antagonism of neuromuscular blockade to prevent postoperative residual muscle weakness.
NeuroWave Systems is dedicated to developing innovative brain monitoring and drug delivery medical devices, powered by state-of-the-art signal processing and control engineering technologies. Our vision is to pioneer automation in anesthesia for improved and safer patient care.
NeuroWave is proud to offer the NeuroSENSE® Monitor with EasyPrep™ electrodes, the latest generation of brain monitors for patient-customized anesthesia and sedation delivery. The NeuroSENSE Monitor represents the latest generation of brain monitors for patient-customized anesthesia and sedation, powered by leading-edge signal acquisition and processing technologies. This unique bilateral brain monitor calculates and displays independent indices of anesthetic effect for each side of the brain, with an instantaneous response to changes in patient state.
For the first time, physicians in the OR and ICU can track simultaneously, and without delay, anesthetic effect measures for each brain hemisphere. Unlike monitoring a single index derived from one or both hemispheres, independent bilateral indices allow clinicians to easily spot any hemispheric differences due to, e.g., underlying pathologies or unrecognized artifacts. This added insight into the patient's brain assists anesthesia providers to make optimal decisions for safer and improved patient care.
NeuroWave R&D efforts are dedicated to adding to our growing portfolio of innovative medical device technologies. We are pioneering systems that will automate anesthesia and sedation delivery. Our portable and easy-to-use research platforms vertically integrate proprietary infusion
Noninvasix recognized that there are no continuous and noninvasive monitors of the “right side of the heart.” We will break this status quo by being the first company to measure central venous oxygen saturation noninvasively and continuously. In doing so, Noninvasix will monitor the severity of sepsis and septic shock non-invasively, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real time. Incorporating Noninvasix into the ICU workflow allows clinicians the potential to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes.
Future developments, enhancements, and evidence will expand our technology's use and clinical impact in other patient populations, indications and settings.
Noninvasix is backed by 15 years of optoacoustic research and more than $6.5 million in research grants.